SEC 13F Intelligence

Leonard Green & Partners, L.P. / BMY-R

Leonard Green & Partners, L.P.’s Bristol-Myers Squibb Contingen Position

Does Leonard Green & Partners, L.P. own Bristol-Myers Squibb Contingen (BMY-R)? Not currently — the last reported position was 2.15M shares worth $11M in Q4 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$11M
Q4 2020
Shares
2.15M
% of Portfolio
+0.15%
Quarters Held
3
position exited

Position History BMY-R

Reported value by quarter
Q4 ’19: $211,000Q4 ’19Q3 ’20: $1MQ3 ’20Q4 ’20: $11MQ4 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20202.15M$11M+0.15%
Q3 2020500.0K$1M+0.06%
Q4 201970.0K$211,000+0.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Leonard Green & Partners, L.P.’s full portfolio or all institutional holders of BMY-R.